Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib

Völkel, Sara; Tarawneh, Thomas S.; Sacher, Laura; Bhagwat, Aditya M.; Karim, Ihab; Mack, Hildegard I. D.; Wiesmann, Thomas; Beutel, Gjörn; Hoyer, Joachim; Keller, Christian; Renz, Harald; Burchert, Andreas; Neubauer, Andreas; Graumann, Johannes; Skevaki, Chrysanthi; Mack, Elisabeth K. M.

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib

Background: Acute respiratory distress syndrome (ARDS) in corona virus disease 19 (COVID-19) is triggered by hyperinflammation, thus providing a rationale for immunosuppressive treatments. The Janus kinase inhibitor Ruxolitinib (Ruxo) has shown efficacy in severe and critical COVID-19. In this study...

全面介紹

Gespeichert in:

書目詳細資料
Autoren:	Völkel, Sara, Tarawneh, Thomas S., Sacher, Laura, Bhagwat, Aditya M., Karim, Ihab, Mack, Hildegard I. D., Wiesmann, Thomas, Beutel, Gjörn, Hoyer, Joachim, Keller, Christian, Renz, Harald, Burchert, Andreas, Neubauer, Andreas, Graumann, Johannes, Skevaki, Chrysanthi, Mack, Elisabeth K. M.
格式:	Artikel
語言:	英语
出版:	Philipps-Universität Marburg 2023
主題:	SARS-CoV-2 proteomics COVID-19 Medizin acute respiratory distress syndrome Ruxolitinib Medical sciences Medicine
在線閱讀:	PDF-Volltext
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

Publikationen im Open Access gefördert durch die UB

Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib

相似書籍